Insmed to Present at the BIO Investor Forum Conference.RICHMOND, Va. -- Insmed Incorporated (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : INSM INSM Initiative Neue Soziale Marktwirtschaft (German) INSM Integrated Network and Systems Management ) today announced that Philip J. Young, Chief Business Officer of Insmed, will present a corporate overview Wednesday, October 19 at 11:40am PT (2:40pm ET) during the BIO Investor Forum Conference in San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden . Investors may access a live audio webcast of the presentation via Insmed's corporate website, www.insmed.com. A replay of the presentation will be available for one week. About Insmed Insmed is a biopharmaceutical company focused on the discovery and development of drug candidates for the treatment of metabolic diseases metabolic disease, n a disorder that causes dysfunction of the metabolic action of the body, resulting in loss of control of homeostasis. paraneoplastic syndrome and endocrine disorders with unmet medical needs. For more information, please visit http://www.insmed.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion